These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8194887)

  • 41. Epidermal growth factor (EGF)- and transforming growth factor alpha-stimulated invasion and growth of follicular thyroid cancer cells can be blocked by antagonism to the EGF receptor and tyrosine kinase in vitro.
    Hölting T; Siperstein AE; Clark OH; Duh QY
    Eur J Endocrinol; 1995 Feb; 132(2):229-35. PubMed ID: 7858744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.
    Hoffmann T; Hafner D; Ballo H; Haas I; Bier H
    Anticancer Res; 1997; 17(6D):4419-25. PubMed ID: 9494544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EGF stimulates anchorage-independent growth of a human bladder carcinoma cell line (KU1) with an amplified and over-expressed EGF receptor gene.
    Ishikawa J; Maeda S; Sugiyama T; Nishimura R; Mizoguchi A; Kamidono S
    Int J Cancer; 1989 Dec; 44(6):1000-4. PubMed ID: 2606569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
    Larbouret C; Robert B; Navarro-Teulon I; Thèzenas S; Ladjemi MZ; Morisseau S; Campigna E; Bibeau F; Mach JP; Pèlegrin A; Azria D
    Clin Cancer Res; 2007 Jun; 13(11):3356-62. PubMed ID: 17545543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidermal growth factor receptor expression in human malignant glioma: in vitro and in vivo effects of application of monoclonal antibodies to the epidermal growth factor receptor.
    Westphal M; Hamel W; Zirkel D; Herrmann HD; Bilzer T; Reifenberger G; Schober R; Wechsler W; Albert FK; Behnke J
    Recent Results Cancer Res; 1994; 135():171-84. PubMed ID: 8047692
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice.
    Aboud-Pirak E; Hurwitz E; Pirak ME; Bellot F; Schlessinger J; Sela M
    J Natl Cancer Inst; 1988 Dec; 80(20):1605-11. PubMed ID: 3193478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of dexamethasone on the growth and epidermal growth factor receptor expression of the OVCA 433 ovarian cancer cells.
    Ferrandina G; Scambia G; Benedetti Panici P; Bonanno G; De Vincenzo R; Rumi C; Bussa S; Genuardi M; Romano Spica V; Mancuso S
    Mol Cell Endocrinol; 1992 Feb; 83(2-3):183-93. PubMed ID: 1372274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer.
    Teramoto T; Onda M; Tokunaga A; Asano G
    Cancer; 1996 Apr; 77(8 Suppl):1639-45. PubMed ID: 8608556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells.
    Rabiasz GJ; Langdon SP; Bartlett JM; Crew AJ; Miller EP; Scott WN; Smyth JF; Miller WR
    Br J Cancer; 1992 Aug; 66(2):254-9. PubMed ID: 1503897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
    Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
    J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.
    O-charoenrat P; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Clin Exp Metastasis; 1999; 17(7):631-9. PubMed ID: 10845563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
    Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
    Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium.
    Yanagihara K; Kamada N; Tsumuraya M; Amano F
    Int J Cancer; 1993 May; 54(2):200-7. PubMed ID: 8387462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy.
    Berstad MB; Cheung LH; Berg K; Peng Q; Fremstedal AS; Patzke S; Rosenblum MG; Weyergang A
    Oncogene; 2015 Oct; 34(44):5582-92. PubMed ID: 25684137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The linear C-terminal regions of epidermal growth factor (EGF) and transforming growth factor-alpha bind to different epitopes on the human EGF receptor.
    Lenferink AE; De Roos AD; Van Vugt MJ; Van de Poll ML; Van Zoelen EJ
    Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):147-51. PubMed ID: 9806896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy.
    Yang XD; Jia XC; Corvalan JR; Wang P; Davis CG; Jakobovits A
    Cancer Res; 1999 Mar; 59(6):1236-43. PubMed ID: 10096554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell lines.
    Crew AJ; Langdon SP; Miller EP; Miller WR
    Eur J Cancer; 1992; 28(2-3):337-41. PubMed ID: 1591048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
    Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation.
    Harari PM; Huang SM
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):427-33. PubMed ID: 11173137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy.
    Bleeker WK; Lammerts van Bueren JJ; van Ojik HH; Gerritsen AF; Pluyter M; Houtkamp M; Halk E; Goldstein J; Schuurman J; van Dijk MA; van de Winkel JG; Parren PW
    J Immunol; 2004 Oct; 173(7):4699-707. PubMed ID: 15383606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.